drugset / Trial / NCT07290205
Remimazolam NeuroImaging
Phase 0
Recruiting
60 enrolled
Keith M Vogt
National Institute of General Medical Sciences (NIGMS) · collab
NaSingle-groupOpen-labelBasic science
Summary
This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task
Timeline
- Start
- 2026-03-27
- Primary completion
- 2027-12-01
- Completion
- 2027-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | — | Intravenous |
Indications
No indication recorded.